NZ600499A - Hatching fluid enzymes and uses thereof - Google Patents

Hatching fluid enzymes and uses thereof

Info

Publication number
NZ600499A
NZ600499A NZ60049910A NZ60049910A NZ600499A NZ 600499 A NZ600499 A NZ 600499A NZ 60049910 A NZ60049910 A NZ 60049910A NZ 60049910 A NZ60049910 A NZ 60049910A NZ 600499 A NZ600499 A NZ 600499A
Authority
NZ
New Zealand
Prior art keywords
sequence
polypeptide
seq
set forth
disclosed
Prior art date
Application number
NZ60049910A
Other languages
English (en)
Inventor
Bernt Walther
Hans Kristian Leren
Original Assignee
Aqua Bio Technology Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41572950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ600499(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aqua Bio Technology Asa filed Critical Aqua Bio Technology Asa
Priority to NZ62794110A priority Critical patent/NZ627941A/en
Publication of NZ600499A publication Critical patent/NZ600499A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24066—Choriolysin L (3.4.24.66)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
NZ60049910A 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof NZ600499A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ62794110A NZ627941A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0921001A GB0921001D0 (en) 2009-11-30 2009-11-30 Products and uses
PCT/EP2010/068509 WO2011064384A1 (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Publications (1)

Publication Number Publication Date
NZ600499A true NZ600499A (en) 2014-09-26

Family

ID=41572950

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ60049910A NZ600499A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof
NZ62794110A NZ627941A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ62794110A NZ627941A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Country Status (17)

Country Link
US (3) US9133256B2 (enExample)
EP (1) EP2506825B2 (enExample)
JP (1) JP5913117B2 (enExample)
KR (1) KR101842521B1 (enExample)
CN (2) CN104436163B (enExample)
AU (2) AU2010323022B2 (enExample)
CA (1) CA2781834C (enExample)
CL (1) CL2012001380A1 (enExample)
ES (1) ES2741586T5 (enExample)
GB (1) GB0921001D0 (enExample)
IN (1) IN2012DN04918A (enExample)
MX (1) MX340231B (enExample)
NZ (2) NZ600499A (enExample)
PL (1) PL2506825T5 (enExample)
RU (1) RU2595399C2 (enExample)
WO (1) WO2011064384A1 (enExample)
ZA (1) ZA201204066B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201110777D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110783D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
US9169203B2 (en) * 2012-01-06 2015-10-27 Novus International, Inc. Sulfoxide-based surfactants
DK2691069T3 (en) 2012-01-23 2016-11-28 Restorsea Llc Cosmetics
JP6125036B2 (ja) * 2012-12-21 2017-05-10 アクア バイオ テクノロジー エーエスエー 魚の孵化液から得られる化粧品組成物
GB201223330D0 (en) * 2012-12-21 2013-02-06 Aqua Bio Technology Asa Products, methods and uses
KR101505294B1 (ko) * 2013-06-19 2015-03-23 강릉원주대학교산학협력단 켈로이드 또는 흉터 형성을 감소시키기 위한 조성물
EP3091961A4 (en) 2013-12-13 2017-11-15 Restorsea, LLC Exfoliative hair retention-promoting formulation
KR20170003691A (ko) 2014-05-16 2017-01-09 레스토시, 엘엘씨 2상 화장료
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
US12458687B2 (en) 2019-07-05 2025-11-04 Regenics As Wound debridement systems
CN110592054B (zh) * 2019-08-29 2021-02-12 中国科学院南海海洋研究所 海马孵化酶基因及其编码蛋白和应用
KR20240100757A (ko) * 2022-12-23 2024-07-02 순천향대학교 산학협력단 철갑상어 점액질을 유효성분으로 포함하는 상처 치유 또는 여드름 치료용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3393559B2 (ja) * 1993-10-15 2003-04-07 株式会社ノエビア 皮膚外用剤
FR2743723B1 (fr) 1996-01-18 1998-04-17 Texinfine Sa Utilisation d'extrait des plantes de la famille des dictyotales en vue de la realisation de preparations destinees a remanier les elements glycosyles de la matrice extracellulaire de tissus vivants
NO314594B1 (no) † 1997-12-11 2003-04-14 Aqua Bio Technology As Ikke-selvdegraderende endoprotease, fremgangsmåte for fremstilling samt anvendelser av denne
CA2333159A1 (en) 1998-05-27 1999-12-02 Lauras As Method
FR2792202B1 (fr) * 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
JP4643800B2 (ja) * 2000-06-16 2011-03-02 エム・ディジャパン株式会社 プロテアーゼ阻害剤
JP2004529623A (ja) 2001-02-20 2004-09-30 レキシコン・ジェネティクス・インコーポレーテッド 新規プロテアーゼおよびそれをコードするポリヌクレオチド
US20050074865A1 (en) 2002-08-27 2005-04-07 Compound Therapeutics, Inc. Adzymes and uses thereof
GB0230006D0 (en) * 2002-12-23 2003-01-29 Ares Trading Sa Proteins
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
WO2005046710A2 (en) * 2003-11-06 2005-05-26 Genencor International, Inc. Tgf-beta binding and supported peptides
JP4834554B2 (ja) 2003-11-06 2011-12-14 ジェネンコー・インターナショナル・インク 糸状菌におけるプロテアーゼ抑制剤及びその変異体の発現
US8357365B2 (en) * 2005-02-14 2013-01-22 The Regents Of The University Of California Granulysin peptides and methods of use thereof
JP2008094726A (ja) 2006-10-06 2008-04-24 Towa Koso Kk マイクロバブル洗浄用組成物、マイクロバブル洗浄方法及びマイクロバブル洗浄装置

Also Published As

Publication number Publication date
CN102724954A (zh) 2012-10-10
US9624483B2 (en) 2017-04-18
MX340231B (es) 2016-07-01
PL2506825T3 (pl) 2019-11-29
ES2741586T3 (es) 2020-02-11
AU2015202010B2 (en) 2017-04-20
AU2015202010A1 (en) 2015-05-14
NZ627941A (en) 2015-01-30
PL2506825T5 (pl) 2023-07-10
AU2010323022B2 (en) 2015-05-14
US9133256B2 (en) 2015-09-15
US20170189478A1 (en) 2017-07-06
EP2506825A1 (en) 2012-10-10
KR20120115291A (ko) 2012-10-17
BR112012012909A2 (pt) 2017-04-18
KR101842521B1 (ko) 2018-03-27
JP2013511971A (ja) 2013-04-11
CN104436163B (zh) 2017-08-11
CL2012001380A1 (es) 2012-11-30
MX2012006090A (es) 2012-09-07
US9950031B2 (en) 2018-04-24
ZA201204066B (en) 2013-08-28
JP5913117B2 (ja) 2016-04-27
WO2011064384A1 (en) 2011-06-03
EP2506825B1 (en) 2019-05-08
GB0921001D0 (en) 2010-01-13
ES2741586T5 (es) 2023-08-18
CA2781834C (en) 2019-02-12
EP2506825B2 (en) 2023-05-31
US20120309689A1 (en) 2012-12-06
US20160053249A1 (en) 2016-02-25
RU2012127298A (ru) 2014-01-20
CA2781834A1 (en) 2011-06-03
AU2010323022A1 (en) 2012-06-21
CN104436163A (zh) 2015-03-25
IN2012DN04918A (enExample) 2015-09-25
CN102724954B (zh) 2018-07-27
RU2595399C2 (ru) 2016-08-27

Similar Documents

Publication Publication Date Title
NZ600499A (en) Hatching fluid enzymes and uses thereof
CN104968360B (zh) 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物
CN114206905A (zh) 一种具有改善皮肤状况活性的肽及其用途
TW201109039A (en) Cosmetic uses of modified stressed yeast extracts and related compositions
KR101918240B1 (ko) 미백 활성이 우수한 펩타이드, 및 이의 용도
KR101889322B1 (ko) 주름 개선 및 항노화 효과를 가지는 펩타이드, 및 이의 용도
JP2024075684A (ja) 皮膚症状を改善するためのポリペプチドおよび方法
NZ592911A (en) Leukolectins and uses thereof
KR101869783B1 (ko) 미백 활성이 우수한 펩타이드, 및 이의 용도
JP2011130725A (ja) Ｌｎａオリゴヌクレオチドとそれを含有する化粧品
KR102077983B1 (ko) 피부 주름 개선 및 미백용 조성물
WO2010102988A1 (en) Skin care product
TWI423810B (zh) 舞茸萃取物及含有其的用於促進玻尿酸產生的組成物
KR101305274B1 (ko) 콜라겐 합성 촉진용 조성물
KR101218898B1 (ko) 콜라겐 합성 촉진용 조성물
WO2006088945A2 (en) Granulysin peptides and methods of use thereof
JP7733230B2 (ja) 抗老化活性を有するペプチド及びその用途
KR101886123B1 (ko) 주름 개선용 펩타이드, 및 이의 용도
KR101900745B1 (ko) 주름 개선 및 미백 효과를 가지는 펩타이드, 및 이의 용도
Liang et al. Preparation, identification, and anti-melanogenesis activity of royal jelly protein peptides
Rodan et al. Bioactive peptides
CN100534410C (zh) 水蛭蛋白酶抑素在化妆品中的应用
KR20180019964A (ko) 피부 상태 개선 효과를 가지는 펩타이드, 및 이의 용도
KR102663334B1 (ko) 피부 탄력 증진 및 장벽 강화용 펩타이드, 및 이의 화장료 용도
JP4861686B2 (ja) 神経栄養因子−４（Ｎｅｕｒｏｔｒｏｐｈｉｎ−４）アンタゴニスト

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 NOV 2017 BY BALDWINS INTELLECTUAL PROPERTY

Effective date: 20150408

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2018 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20171122

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2019 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20181120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2020 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20191121

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2021 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20201120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2022 BY CAMILLA WELLIN / CPA GLOBAL CLARIVATE

Effective date: 20211120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2023 BY PATENT ANNUITIES 2022-11-21

Effective date: 20221121

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2024 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20231124

LAPS Patent lapsed